Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle Cells

Aortic aneurysm is a common cardiovascular disease characterised by continuous dilation of the aorta, and this disease places a heavy burden on healthcare worldwide. Few drugs have been suggested to be effective in controlling the progression of aortic aneurysms. Preclinical drug responses from trad...

Full description

Bibliographic Details
Main Authors: Nan Chen, Mieradilijiang Abudupataer, Sisi Feng, Shichao Zhu, Wenrui Ma, Jun Li, Hao Lai, Kai Zhu, Chunsheng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2021.627877/full
_version_ 1818676186339868672
author Nan Chen
Nan Chen
Mieradilijiang Abudupataer
Mieradilijiang Abudupataer
Sisi Feng
Shichao Zhu
Shichao Zhu
Wenrui Ma
Wenrui Ma
Jun Li
Jun Li
Hao Lai
Hao Lai
Kai Zhu
Kai Zhu
Chunsheng Wang
Chunsheng Wang
author_facet Nan Chen
Nan Chen
Mieradilijiang Abudupataer
Mieradilijiang Abudupataer
Sisi Feng
Shichao Zhu
Shichao Zhu
Wenrui Ma
Wenrui Ma
Jun Li
Jun Li
Hao Lai
Hao Lai
Kai Zhu
Kai Zhu
Chunsheng Wang
Chunsheng Wang
author_sort Nan Chen
collection DOAJ
description Aortic aneurysm is a common cardiovascular disease characterised by continuous dilation of the aorta, and this disease places a heavy burden on healthcare worldwide. Few drugs have been suggested to be effective in controlling the progression of aortic aneurysms. Preclinical drug responses from traditional cell culture and animals are usually controversial. An effective in vitro model is of great demand for successful drug screening. In this study, we induced an in vitro microphysiological system to test metformin, which is a potential drug for the treatment of aortic aneurysms. Human pluripotent stem cell-derived aortic smooth muscle cells (hPSC-HASMCs) were cultured on an in vitro microphysiological system, which could replicate the cyclic stretch of the human native aortic wall. By using this system, we found that HASMCs were more likely to present a physiologically contractile phenotype compared to static cell cultures. Moreover, we used hPSC-HASMCs in our microphysiological system to perform metformin drug screening. The results showed that hPSC-HASMCs presented a more contractile phenotype via NOTCH 1 signalling while being treated with metformin. This result indicated that metformin could be utilised to rescue hPSC-HASMCs from phenotype switching during aortic aneurysm progression. This study helps to elucidate potential drug targets for the treatment of aortic aneurysms.
first_indexed 2024-12-17T08:39:28Z
format Article
id doaj.art-e9a7849dd648413fa56d9cb31ff78e80
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-17T08:39:28Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-e9a7849dd648413fa56d9cb31ff78e802022-12-21T21:56:23ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852021-03-01910.3389/fbioe.2021.627877627877Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle CellsNan Chen0Nan Chen1Mieradilijiang Abudupataer2Mieradilijiang Abudupataer3Sisi Feng4Shichao Zhu5Shichao Zhu6Wenrui Ma7Wenrui Ma8Jun Li9Jun Li10Hao Lai11Hao Lai12Kai Zhu13Kai Zhu14Chunsheng Wang15Chunsheng Wang16Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, ChinaDepartment of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaAortic aneurysm is a common cardiovascular disease characterised by continuous dilation of the aorta, and this disease places a heavy burden on healthcare worldwide. Few drugs have been suggested to be effective in controlling the progression of aortic aneurysms. Preclinical drug responses from traditional cell culture and animals are usually controversial. An effective in vitro model is of great demand for successful drug screening. In this study, we induced an in vitro microphysiological system to test metformin, which is a potential drug for the treatment of aortic aneurysms. Human pluripotent stem cell-derived aortic smooth muscle cells (hPSC-HASMCs) were cultured on an in vitro microphysiological system, which could replicate the cyclic stretch of the human native aortic wall. By using this system, we found that HASMCs were more likely to present a physiologically contractile phenotype compared to static cell cultures. Moreover, we used hPSC-HASMCs in our microphysiological system to perform metformin drug screening. The results showed that hPSC-HASMCs presented a more contractile phenotype via NOTCH 1 signalling while being treated with metformin. This result indicated that metformin could be utilised to rescue hPSC-HASMCs from phenotype switching during aortic aneurysm progression. This study helps to elucidate potential drug targets for the treatment of aortic aneurysms.https://www.frontiersin.org/articles/10.3389/fbioe.2021.627877/fullaortic aneurysmmetformindrug screeninghuman pluripotent stem cellsmicrophysiological system
spellingShingle Nan Chen
Nan Chen
Mieradilijiang Abudupataer
Mieradilijiang Abudupataer
Sisi Feng
Shichao Zhu
Shichao Zhu
Wenrui Ma
Wenrui Ma
Jun Li
Jun Li
Hao Lai
Hao Lai
Kai Zhu
Kai Zhu
Chunsheng Wang
Chunsheng Wang
Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle Cells
Frontiers in Bioengineering and Biotechnology
aortic aneurysm
metformin
drug screening
human pluripotent stem cells
microphysiological system
title Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle Cells
title_full Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle Cells
title_fullStr Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle Cells
title_full_unstemmed Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle Cells
title_short Engineering a Human Pluripotent Stem Cell-Based in vitro Microphysiological System for Studying the Metformin Response in Aortic Smooth Muscle Cells
title_sort engineering a human pluripotent stem cell based in vitro microphysiological system for studying the metformin response in aortic smooth muscle cells
topic aortic aneurysm
metformin
drug screening
human pluripotent stem cells
microphysiological system
url https://www.frontiersin.org/articles/10.3389/fbioe.2021.627877/full
work_keys_str_mv AT nanchen engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT nanchen engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT mieradilijiangabudupataer engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT mieradilijiangabudupataer engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT sisifeng engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT shichaozhu engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT shichaozhu engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT wenruima engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT wenruima engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT junli engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT junli engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT haolai engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT haolai engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT kaizhu engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT kaizhu engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT chunshengwang engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells
AT chunshengwang engineeringahumanpluripotentstemcellbasedinvitromicrophysiologicalsystemforstudyingthemetforminresponseinaorticsmoothmusclecells